Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients.

Ridker PM, Revkin J, Amarenco P, Brunell R, Curto M, Civeira F, Flather M, Glynn RJ, Gregoire J, Jukema JW, Karpov Y, Kastelein JJP, Koenig W, Lorenzatti A, Manga P, Masiukiewicz U, Miller M, Mosterd A, Murin J, Nicolau JC, Nissen S, Ponikowski P, Santos RD, Schwartz PF, Soran H, White H, Wright RS, Vrablik M, Yunis C, Shear CL, Tardif JC; SPIRE Cardiovascular Outcome Investigators.

N Engl J Med. 2017 Apr 20;376(16):1527-1539. doi: 10.1056/NEJMoa1701488. Epub 2017 Mar 17.

PMID:
28304242
2.

[Role of implantable loop recorder in the clinical diagnosis of syncope: results of the introduction of an effective diagnostic tool].

Somlói M, Toldy-Schedel E, Nényei Z, Böszörményi R, Tomcsányi J.

Orv Hetil. 2015 Apr;156(15):609-13. doi: 10.1556/OH.2015.30124. Hungarian.

PMID:
25845320
3.

Ivabradine and AV conduction.

Tomcsányi J, Toldy-Schedel E, Somlói M.

Int J Cardiol. 2015 Feb 15;181:53-4. doi: 10.1016/j.ijcard.2014.12.011. Epub 2014 Dec 3. No abstract available.

PMID:
25482278
4.

Interaction between digoxin and dronedarone in the PALLAS trial.

Hohnloser SH, Halperin JL, Camm AJ, Gao P, Radzik D, Connolly SJ; PALLAS investigators.

Circ Arrhythm Electrophysiol. 2014 Dec;7(6):1019-25. doi: 10.1161/CIRCEP.114.002046. Epub 2014 Nov 6.

5.

Efficacy and safety of celivarone, with amiodarone as calibrator, in patients with an implantable cardioverter-defibrillator for prevention of implantable cardioverter-defibrillator interventions or death: the ALPHEE study.

Kowey PR, Crijns HJ, Aliot EM, Capucci A, Kulakowski P, Radzik D, Roy D, Connolly SJ, Hohnloser SH; ALPHEE Study Investigators.

Circulation. 2011 Dec 13;124(24):2649-60. doi: 10.1161/CIRCULATIONAHA.111.072561. Epub 2011 Nov 14.

6.

Dronedarone in high-risk permanent atrial fibrillation.

Connolly SJ, Camm AJ, Halperin JL, Joyner C, Alings M, Amerena J, Atar D, Avezum Á, Blomström P, Borggrefe M, Budaj A, Chen SA, Ching CK, Commerford P, Dans A, Davy JM, Delacrétaz E, Di Pasquale G, Diaz R, Dorian P, Flaker G, Golitsyn S, Gonzalez-Hermosillo A, Granger CB, Heidbüchel H, Kautzner J, Kim JS, Lanas F, Lewis BS, Merino JL, Morillo C, Murin J, Narasimhan C, Paolasso E, Parkhomenko A, Peters NS, Sim KH, Stiles MK, Tanomsup S, Toivonen L, Tomcsányi J, Torp-Pedersen C, Tse HF, Vardas P, Vinereanu D, Xavier D, Zhu J, Zhu JR, Baret-Cormel L, Weinling E, Staiger C, Yusuf S, Chrolavicius S, Afzal R, Hohnloser SH; PALLAS Investigators.

N Engl J Med. 2011 Dec 15;365(24):2268-76. doi: 10.1056/NEJMoa1109867. Epub 2011 Nov 14. Erratum in: N Engl J Med. 2012 Feb 16;366(7):672.

7.

[Transient left ventricular dysfunction: special form of stress cardiomyopathy].

Tomcsányi J, Somlói M, Frész T, Arabadzisz H, Toldy-Schedel E, Sármán B, Zsoldos A, Nagy E, Farbaky Z.

Orv Hetil. 2008 Feb 24;149(8):347-52. doi: 10.1556/OH.2008.28181. Hungarian.

PMID:
18281230
8.

Switching beta-blocker therapy in chronic heart failure.

Tomcsányi J, Wettstein A, Toldy-Schedel E, Somlói M.

Int J Cardiol. 2008 Nov 28;130(3):497-9. Epub 2007 Aug 16.

PMID:
17707095
9.

Unusual bigeminal rhythms.

Tomcsányi J, Toldy-Schedel E, Nényei Z, Bózsik B.

J Electrocardiol. 2007 Nov-Dec;40(6):482-3. Epub 2007 May 29. No abstract available.

PMID:
17532335
10.

Hungary: palliative care--a new challenge.

Muszbek K, Toldy-Schedel E.

J Pain Symptom Manage. 2002 Aug;24(2):188-90. Review. No abstract available.

PMID:
12231141

Supplemental Content

Loading ...
Support Center